References
- HallekMBergsagelPLAndersonKCMultiple myeloma: increasing evidence for a multistep transformation processBlood19989113219414264
- OriolAMultiple myeloma with extramedullary diseaseAdv Ther201128Suppl 71622105527
- UppalHSHarrisonPExtramedullary plasmacytoma of the larynx presenting with upper airway obstruction in a patient with long-standing IgD myelomaJ Laryngol Otol2001115974574611564308
- ChettyRBramdevAReddyADPrimary extramedullary plasmacytoma of the esophagusAnn Diagn Pathol20037317417912808570
- ChimCSWongWMNichollsJChungLPLiangRExtramedullary sites of involvement in hematologic malignancies: case 3. Hemorrhagic gastric plasmacytoma as the primary presentation in multiple myelomaJ Clin Oncol200220134434711773190
- KintzerJSJrRosenowEC3rdKyleRAThoracic and pulmonary abnormalities in multiple myeloma. A review of 958 casesArch Intern Med19781385727730646535
- FernandezLACoubanSSyRMillerRAn unusual presentation of extramedullary plasmacytoma occurring sequentially in the testis, subcutaneous tissue, and heartAm J Hematol200167319419611391718
- GiulianiNCaramattiCRotiGHematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testesJ Clin Oncol20032191887188812721268
- GreenTGrantJPyeRMarcusRMultiple primary cutaneous plasmacytomasArch Dermatol199212879629651626965
- RosenblumMDBredesonCNChangCCRizzoJDSubcutaneous plasmacytomas with tropism to sites of previous trauma in a multiple myeloma patient treated with an autologous bone marrow transplantAm J Hematol200372427427712666140
- AlegreAMartinez-ChamorroCFernandez-RanadaJMMassive myelomatous ascites responsive to VAD chemotherapy and autologous stem cell transplantationBone Marrow Transplant199924334334410455378
- PetrucciMTTirindelliMCDe MuroMMartiniVLeviAMandelliFExtramedullary liver plasmacytoma a rare presentationLeuk Lymphoma20034461075107612854914
- FujikataSTanjiNAokiKOhokaHHojoNYokoyamaMExtramedullary plasmacytoma arising from an adrenal glandUrology200260351412350502
- MenkeDMHornyHPGriesserHPrimary lymph node plasmacytomas (plasmacytic lymphomas)Am J Clin Pathol2001115111912611190797
- FassasABMuwallaFBerrymanTMyeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestationsBr J Haematol2002117110310811918539
- International Myeloma Working GroupCriteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working GroupBr J Haematol2003121574975712780789
- BladéJSamsonDReeceDCriteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow TransplantBr J Haematol19981025111511239753033
- DinseGELagakosSWNonparametric estimation of lifetime and disease onset distributions from incomplete observationsBiometrics19823849219327168795
- CoxDRRegression models and life-tablesJ Roy Stat Soc B1972342187220
- FassasABTWardSMuwallaFMyeloma of the central nervous system: Strong association with unfavorable chromosomal abnormalities and other high-risk disease featuresLeuk Lymphoma200445229130015101714
- Garcia-SanzROrfaoAGonzalezMPrimary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristicsBlood1999933103210379920853
- DimopoulosMAPalumboADelasalleKBAlexanianRPrimary plasma-cell leukaemiaBr J Haematol19948847547597819100
- JancelewiczZTakatsukiKSugaiSPruzanskiWIgD multiple myeloma. Review of 133 casesArch Intern Med1975135187931111472
- DamajGMohtyMVeyNFeatures of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single centerEur J Haematol200473640240615522061
- AliROzkalemkasFOzkanABortezomib and extramedullary disease in multiple myeloma: the shine and dark side of the moonLeuk Res20073181153115516945413
- KaneRCBrossPFFarrellATPazdurRVelcade: US FDA approval for the treatment of multiple myeloma progressing on prior therapyOncologist20038650851314657528
- BoldR“Development of the proteasome inhibitor Velcade (Bortezomib)” by Julian Adams, PhD, and Michael Kauffman, MD, PhDCancer Invest200422230431115199612